Specialty Pharmacy

Study indicated that patients who received radiation 30 days or fewer before their CAR T-cell infusion did not experience serious cytokine release syndrome or neurotoxicity.

Mammography found more effective at detecting breast cancer in men with high risk than for women with an average risk and in detecting the disease before it metastasizes.

Top news of the day across the health care landscape.

Top news of the day across the health care landscape.

Study participants who consumed approximately 500 mg of total flavonoids each day had the lowest risk of a cancer or heart disease-related death.

Study shows that higher levels of PTSD symptoms can be associated with increased risks of ovarian cancer even decades after women experience a traumatic event.

The report is the result of collaboration among experts across the agency and incorporates important input from patients, researchers, and advocates.

In a Pharmacy Times Continuing Education Supplement, Elena E. Perez, MD, PhD, examined the evolution of immunoglobulin [Ig] in its treatment use, including patient populations and potential adverse events.

Patients with diabetes demonstrated a higher likelihood of developing non-Hodgkin lymphoma than those without diabetes, especially among men.

Top news of the day across the health care landscape.

Specialty pharmacies are uniquely positioned to assist prescribers in managing patient care and offsetting administrative burden.

Obesity-associated cancer burden is shifting toward younger individuals, with more dramatic increases in some populations than others.

Top news of the day from across the health care landscape.

Top news of the day across the health care landscape.

Transplanting organ from patients infected with hepatitis C could greatly expand the number of kidneys available and reduce wait times.

Top news of the day across the health care landscape.

New approach involves treating patients with a high dose factor VIII concentrates along with emicizumab, a modification of the standard immune tolerance induction.

Top news of the day from across the health care landscape.

Patients with metastatic colorectal cancer harboring certain non-V600 BRAF mutations may benefit from anti-EGFR treatment.

The FDA approval of pembrolizumab plus lenvatinib for this new indication is the first under a new international collaboration with Australia and Canada.

Two phase 3 studies showed that ofatumumab was superior to teriflunomide (Aubagio) in patients with relapsing forms of multiple sclerosis.

Research demonstrates a new direction in cell signaling and treatment for chronic inflammatory diseases such as psoriasis, asthma, and HIV.

The annual National Association of Specialty Pharmacy annual meeting shed light on the significant role these caregivers play in patient care.

The significant jump in hospital-owned specialty pharmacies bolsters the belief that health system leaders increasingly understand how these services enable their organizations to enhance patient care and achieve market differentiation.

Top news of the week from Specialty Pharmacy Times.

Study finds association between obesity and a greater burden of symptoms and distress among patients with breast or prostate cancer.

Puma’s supplemental New Drug Application is seeking approval for the use neratinib (Nerlynx) plus capecitabine as a third-line treatment in patients with human epidermal growth receptor 2-positive metastatic breast cancer.

New updates to immunization guidelines in multiple sclerosis outline recommendations on vaccination decisions for patients.

Dietary interventions that raise levels of high-density lipoprotein, or good cholesterol, may affect fatigue symptoms in multiple sclerosis.